Members of the PrecisionLife team will join leaders from the likes of Sunovion, Merck, Takeda, Lundbeck, BioXcel and MAPS online at the 4th Annual Neuropsychiatric Drug Development Summit to help us meet unmet needs in various neuropsychiatric disorders including schizophrenia, depression and bi-polar.
PrecisionLife is seeking to meet with collaborative R&D partners to progress our pipeline of precision medicine programs across a range of neuropsychiatric diseases.